Gonorrhoea - Annual Epidemiological Report for 2017
In 2017, 89 239 confirmed gonorrhoea cases were reported in 27 countries, an increase of 17% compared with 2016. The overall crude notification rate was 22.2 cases per 100 000 population. Rates of reported gonorrhoea infection vary considerably across Europe, with higher rates reported in northern Europe. Men who have sex with men (MSM) accounted for almost half of the reported cases (47%) in 2017. The overall notification rate increased in 2017 following the slight reduction seen in 2016.
Read more on the ECDC website
Gonorrhoea cases on the rise across Europe
Following a decline in notification rates in 2016, the number of gonorrhoea cases has gone up by 17% across the reporting EU/EEA countries with more than 89 000 confirmed diagnoses in 2017 – more than 240 cases a day.
Presentation: Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
See all Annual Epidemiological Report for 2017
Gonorrhoea is a sexually transmitted infection (STI) caused by Neisseria gonorrhoeae bacteria.Read more
Gonococcal antimicrobial susceptibility surveillance in Europe, 2016
30 Aug 2018 - The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by ECDC since 2009. This surveillance is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform treatment guidelines.
European Test Finder
Find out where you can have a test for HIV, hepatitis or other sexually transmitted infections across Europe. With the European Test Finder, it only takes a few seconds to locate a testing site near you.Read more
Public health guidance on active case finding of communicable diseases in prison settings
23 May 2018 - This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.